GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Polynovo Ltd (OTCPK:CALZF) » Definitions » Days Sales Outstanding

Polynovo (Polynovo) Days Sales Outstanding : 58.07 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Polynovo Days Sales Outstanding?

Polynovo's average Accounts Receivable for the six months ended in Dec. 2023 was $10.04 Mil. Polynovo's Revenue for the six months ended in Dec. 2023 was $31.56 Mil. Hence, Polynovo's Days Sales Outstanding for the six months ended in Dec. 2023 was 58.07.

The historical rank and industry rank for Polynovo's Days Sales Outstanding or its related term are showing as below:

CALZF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 44.35   Med: 49.83   Max: 102.14
Current: 56.36

During the past 13 years, Polynovo's highest Days Sales Outstanding was 102.14. The lowest was 44.35. And the median was 49.83.

CALZF's Days Sales Outstanding is ranked better than
60.62% of 810 companies
in the Medical Devices & Instruments industry
Industry Median: 64.2 vs CALZF: 56.36

Polynovo's Days Sales Outstanding increased from Dec. 2022 (44.26) to Dec. 2023 (58.07).


Polynovo Days Sales Outstanding Historical Data

The historical data trend for Polynovo's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polynovo Days Sales Outstanding Chart

Polynovo Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 57.55 44.47 47.83 48.41 50.78

Polynovo Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 58.47 46.40 44.26 53.16 58.07

Competitive Comparison of Polynovo's Days Sales Outstanding

For the Medical Devices subindustry, Polynovo's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Polynovo's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Polynovo's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Polynovo's Days Sales Outstanding falls into.



Polynovo Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Polynovo's Days Sales Outstanding for the fiscal year that ended in Jun. 2023 is calculated as

Days Sales Outstanding (A: Jun. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2022 ) + Accounts Receivable (A: Jun. 2023 )) / count ) / Revenue (A: Jun. 2023 )*Days in Period
=( (3.885 + 8.299) / 2 ) / 43.786*365
=6.092 / 43.786*365
=50.78

Polynovo's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (8.299 + 11.786) / 2 ) / 31.559*365 / 2
=10.0425 / 31.559*365 / 2
=58.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Polynovo  (OTCPK:CALZF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Polynovo Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Polynovo's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Polynovo (Polynovo) Business Description

Traded in Other Exchanges
Address
320 Lorimer Street, Unit 2, Port Melbourne, VIC, AUS, 3207
Polynovo earns most of its revenue from U.S. sales of its NovoSorb Biodegradable Temporizing Matrix, or NovoSorb BTM. The product is a patented biodegradable synthetic scaffold to support the regeneration of the dermis when lost through surgery, trauma, burns, or other causes of tissue loss. Once the product is applied to a wound, it takes a few weeks for the dermal layer to fully integrate within the polymer scaffold before a clinician can delaminate the outer layer. A small wound would then close either naturally or with a dressing, while a larger wound would close through a split-skin graft or alternative product such as Avita's RECELL. NovoSorb BTM then slowly degrades to harmless byproducts which are fully absorbed in roughly 18 months.

Polynovo (Polynovo) Headlines

From GuruFocus

Full Year 2020 Polynovo Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024

Polynovo Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024

Polynovo Ltd Investor Update Transcript

By GuruFocus Research 02-13-2024

Half Year 2022 Polynovo Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024

Full Year 2021 Polynovo Ltd Earnings Call Transcript

By GuruFocus Research 02-13-2024

Polynovo Ltd Extraordinary Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024

Polynovo Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-13-2024